ArticleJournal of the American Academy of Dermatology2020
New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Pooled it
- Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.Frontiers in immunologyPooled it
- Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.The Journal of experimental medicine · 2025Article
- "COVID toes": A true viral phenomenon or a diagnosis without a leg to stand on?JAAD international · 2022Review
- Chronic Cutaneous Lupus Erythematosus in a White Population: Dermoscopic Characteristics by Clinical Subtype, Lesion Location and Disease Duration.Dermatology and therapy · 2022Article
- Dermatopathology of COVID-19 infection and vaccination.Pathologie (Heidelberg, Germany) · 2022Review
- Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblainsEuropean journal of dermatology : EJD · 2022Article
- Pandemic chilblains: Are they SARS-CoV-2-related or not?Clinical immunology (Orlando, Fla.) · 2022Article
- Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.Pediatric dermatology · 2022Article
- A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.Journal of cutaneous pathology · 2022Review
- Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib.Frontiers in pediatrics · 2022Article
- COVID-19 and the Human Eye: Conjunctivitis, a Lone COVID-19 Finding - A Case-Control Study.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022Article
- Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.The British journal of dermatology · 2021Observational
- Top 10 acral skin manifestations associated with COVID-19: A scoping review.Dermatologic therapy · 2021Article
- Clinical Patterns and Morphology of COVID-19 Dermatology.Dermatologic clinics · 2021Review
- Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease.Dermatologic clinics · 2021Review
- Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.Dermatologic therapy · 2021Article
- Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.Mayo Clinic proceedings · 2021Review
- COVID toes: where do we stand with the current evidence?International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.